Radnet (RDNT) shares of the quality small cap diagnostics play are coiling in a high tight flag and closed above monthly value high Wednesday as it saw MACD also crossing bullish after the rising 55 day MA held on the recent dip. RDNT reports later next week on 11/11 so still has time to run up higher into the report which seems likely. A move through 70 can see a swift pop to the high from last month above 72 while a bigger breakout looks to be brewing towards 75 and beyond. In September the stock was raised to Overweight at Barclays with a $79 target as one of the clearest AI beneficiaries in Healthcare.